Feb. 16th, 2022

Pharmaceutical

China Greenlights Online Sales of Prescription Drugs in Shenzhen

China officially permits Shenzhen to pilot the online sales of prescription drugs, according to the market-access-relaxing measures released by National Development and Reform Commission and the Ministry of Commerce on Jan. 26.Following the Hainan Free Trade Port, Shenzhen becomes the second place allowed to sell prescription drugs online. Before the pilot programs in Hainan and Shenzhen, no regulations in China have unequivocally allowed the online trade of prescription drugs. However, some provincial governments and third-party e-commerce platforms like Alibaba and JD.com have had a try amid the trend of internet-based diagnosis and treatment in recent years. The online sales of prescription drugs, as an unauthorized activity, has received continuous objections due to public concerns about drug abuse. Therefore, to ensure safety, the pilot measures for Shenzhen only allow prescription drugs to be sold to patients who have the corresponding prescriptions. The prescriptions should come from the Shenzhen Electronic Prescription Center to show that they are reliable and formulated by eligible doctors/pharmacists. The measures also stipulate that drugs subject to special administration by the authority, such as vaccines, blood products, narcotic drugs, psychotropic substances, toxic drugs for medical use, radioactive drugs, and pharmaceutical precursor chemicals, shall not be sold online.

...

READ FULL CONTENT

Related News

Newsletter Subscription

Sign up to receive event invitations, expert insights, timely news alerts, and other updates.

SUBSCRIBE

Contact Us

REACH24H USA

+1 703 596 8055

REACH24H EU

+353 1 8899 951

REACH24H UK

+44 203 5822996

REACH24H China

+86 571 87103805

REACH24H Korea

+82 2 62451610

REACH24H Japan

+03 5005 0662

REACH24H Singapore

+65 80785301

Related Services

How REACH24H Can Help

Services

Industries

Events

Everything You Need to Know about Canadian Natural Health Products Regulations

Company News

Full Image